Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives

February 19, 2020

Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug pricing initiatives circulating in Washington.

To listen to the 15-minute podcast, click here.

Share This Story!